Drug Co. to Begin Bird Flu Clinical Trials (AP)


<p><a href="http://us.rd.yahoo.com/dailynews/rss/health/*http://news.yahoo.com/s/ap/20060126/ap_on_he_me/world_forum_gsk_bird_flu"><img src="http://us.news3.yimg.com/us.i2.yimg.com/p/rids/20060125/i/r3637723667.jpg?x=130&y=67&sig=XIVtPe9q_vx3TVDvsVTPOw--" align="left" height="67" width="130" alt="The GlaxoSmithKline headquarters in Middlesex, England is seen in an undated file photo. GlaxoSmithKline Plc is to start final clinical trials in a bid to find a vaccine against pandemic flu, which experts fear may be triggered by bird flu, its chief executive Jean-Pierre Garnier said. REUTERS/Handout" border="0" /></a>AP - Drug maker GlaxoSmithKline PLC hopes to start clinical trials in early April for its vaccine against the deadly H5N1 bird flu strain, a company executive said Thursday.</p><br clear=all>